Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in China / NCT05256251
Recruiting Observational

Westlake Longevity Cohort

NCT05256251 · tracked via the Priya Life Science China tracker
Sponsor
Westlake University
Phase
Observational
Started
2021-11-15
Last updated
2026-09-29

Condition(s) studied

Aging

Study summary

The Westlake Longevity Cohort (We-Longevity) is a prospective cohort study among centenarians, nonagenarians and senior citizens living in Zhejiang Province, China. The primary aim of this cohort is to characterize the multi-omics molecular characteristics of healthy longevity and their dynamic trajectories. The second aim is to culture the gut microbiota of these elderly people through culturomics. The third aim of We-Longevity is to investigate the association of dietary and lifestyle with the multi-omics molecular characteristics of healthy longevity, and to facilitate the development of personalized nutritional/lifestyle recommendation for the public.

Eligibility

Sex
ALL
Min age
50 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Participants live in Zhejiang Province, China. * Participants intend to remain in Zhejiang Province for ≥3 years. Exclusion Criteria: * Participants with infectious diseases.

Primary outcome measure(s)

  • Physical frailty — 1 year
    Physical frailty will be evaluated by using Fried's criteria.
  • Gut microbiome — 3 months, 1 year
    Fecal microbiome will be analyzed by 16S/ITS rRNA gene sequencing and metagenome sequencing. Furthermore, fecal microbiota will be cultured, picked and identified.

Trial sites (1)

FacilityCityRegionStatus
Lishui Yikang Hospital, Renji Nursing Home, Lihong Nursing Home, Nancheng Nursing Home Lishui Zhejiang Recruiting

More Westlake University trials in China

Study of Clostridioides Difficile in Infants Recruiting
Skin Microbiome of Chinese Population Cohort Study Active, not recruiting
Westlake Frequent-sampling Cohort 2 Active, not recruiting
Westlake Precision Birth Cohort Active, not recruiting
Dynamic Monitoring of Urinary Electrolytes Active, not recruiting

Other trials for the same condition

Adaptive Cognitive Training on Cognitive Function in Elderly Diabetes Patients in the Community Enrolling by invitation
Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE) Recruiting
China Longitudinal Aging and Cognitive Impairment Study Recruiting
Study on Aging and Cognitive Impairment in China Recruiting
Neural Mechanisms of Cognitive Assessment and Rehabilitation for Cognitive Decline Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05256251 on ClinicalTrials.gov ↗ ← All trials in China